By Dennis Thompson HealthDay ReporterWEDNESDAY, July 9, 2025 (HealthDay News) — A common virus once thought harmless to ...

It is also important for motor function, and when it disappears from some regions of the brain, it can cause Parkinson’s disease. That is why levodopa, which our body metabolizes to make dopamine, is ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

Chinese scientists have discovered subtle new earlier signs of Parkinson’s in mice, an advance that may help diagnose the ...

DelveInsight's Parkinson's Disease Pipeline report depicts a robust space with 130+ active players working to develop 150+ ...

Parkinson's disease is traditionally associated with neurological damage in the brain, brought on by a drastic drop in ...

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.